The objective of VetoPhage is to finalize the « proof of concept » and develop innovative tools for the diagnosis and treatment of pathogenic bacteria in livestock and in aquaculture.

Our mission is to improve animal and human health, through our natural, safe and environmentally sustainable phage-platform technology that reduces pathogens with no need of antibiotics.

The goal of the Fagenbank is to develop phage therapy together with doctors.

The Fagenbank is a non-profit initiative at the Delft University of Technology, The Netherlands.

Our mission is to stimulate research into the efficacy and safety of bacteriophage therapy as a treatment method for antibiotic-resistant infections.

JAFRAL is manufacturing phages to highest quality/purity. It can also develop manufacturing process and analytical methods for various types of bacteriophages.

Phage Manufacturer,Biotech,CRO,CRMO

Our mission is to provide on-demand phage expertise, training and wet lab services to biotech companies.

Diagnostic Technology Innovation PLC

We are developing new affinity-based diagnostic assays

Provide natural antimicrobial solution for livestock.

Expertise in phage product development, through 11 years of experience in discovery, preclinical, clinical and regulatory activities dedicated to phage therapy

We are a research group committed to isolate, characterize, and engineer bacteriophages and phage derived proteins for detection and control of gram-negative pathogens. We are currently collecting phages for research and we would be happy to contribute to phage applications in agriculture, food, and medicine.

PhagoMed Biopharma GmbH is an Austrian biotech company focused on the development of human therapeutic applications of phages and phage-derived proteins. Currently, PhagoMed has three active development programs in the fields of periprosthetic joint infections, urinary tract infections and bacterial vaginosis. These development programs are based on the experiences of its clinical co-founders with last-resort treatments, as well as research collaborations with highly renowned scientists and research institutions in Germany and Belgium. Since its incorporation in November 2017, the company has raised more than €5.5 million in private investments and public grants. PhagoMed has a team of twelve highly skilled scientist working on its programs, eight of which at the Campus Vienna Biocenter in Vienna, Austria.

Cytophage is working on the development of synthetic phages to be used as prevention and treatment of bacterial diseases in animals. We are developing this treatment to reduce and/or eliminate antibiotic use.

To provide standard operating procedures for bacteriophage researches and to do bacteriophage researches.

Research to support positive clinical outcomes

"We are the only manufacturer of bacteriophages in Central Asia LLC ""AZIYA IMMUNOPREPARAT"". Today it produces medicinal products under the brand MediPhag
1) Bacteriophage staphylococcal liquid ""MediPhag"" Spray 20ml
2) Bacteriophage staphylococcal liquid ""MediPhag"" 20ml № 4
3) Dysentery bacteriophage polyvalent ""MediPhag"" 20 ml № 4 - liquid for oral administration and oral administration
4) Bacteriophage dysentery polyvalent ""MediPhag"" capsules for oral administration
№ 10
5) Salmonella polyvalent bacteriophage ""MediPhag"" 20 ml № 4 - liquid for oral administration and rectal administration.
6) Salmonella polyvalent bacteriophage ""MediPhag"" capsules for oral administration. № 10.
We are looking for partners for commercial purposes"

Phage Bank,Biotech,Startup,Pharma,Phage Manufacturer

Ibadan Bacteriophage Research Team

Ibadan Bacteriohage Research Team is an undergraduate research group of the University of Ibadan, registered under the HHMI SEAPHAGES early career research programme. The team is focused on active engagement in bacteriophage research, to achieve the vision of bacteriophage therapy as an alternative to antibiotics use in Africa. This is achieved through bacteriophage exploration, characterization and research collaborations. The team is driven by a strong commitment to bridge the existing knowledge gap of undergraduate students in bacteriophage biology and the role of computational biology in addressing the imminent global challenge of antimicrobial resistance.

Fagoterapia LAB s.r.l. is the first Italy-based start up developing antimicrobial therapy based on bacteriophages and their derivatives for treating antibiotic-resistant infections by using innovative tools of artificial intelligence for either standard or personalised cures.

Biotech,Pharma,"Tech (ML, AI, Bioinformatics)"

Creative Biolabs has engaged in phage research for many years, providing services like phage detection, identification, and discovery, small and large-scale phage production, phage purification, phage-based vaccine development, and phage-based therapeutics discovery to assist academic and industry intuitions whose activities are based on bacteriophage functions to fight and prevent bacterial infections and other diseases.

Mikroliz Therapeutic Bacteriophage Bank (MTBB) is established in Turkey which currently has over 800 phages against mainly the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp) pathogens. MTBB is constantly growing with new phages and we are developing quick methods for phage isolation and characterization. Our three-year project titled “Therapeutic Bacteriophage and Lytic Enzyme Bank against Superbugs” is supported by government,TUBITAK (The Scientific and Technological Research Council of Turkey).

Phage Bank,Biotech,Phage Manufacturer

Focuses on synthetic biology using and producing phosphate analogues. Has technology for the production of phosphorothioate single stranded phage DNA. Interested in those who make phage DNA.

We are developing phage cocktails containing natural phages.

Democratize phage use - Starting in aquaculture

Biotech,Pharma,Phage Bank,Phage Manufacturer

ExoLytics is an early-stage biotechnology startup focused on developing novel, innovative, and disruptive technologies to combat drug-resistant bacterial diseases. The Company harnesses endolysins, enzymes present in nature, to engineer safe, rapid, targeted, and effective antimicrobial therapies. The rise in antimicrobial drug resistance (AMR), coupled with shrinking treatment options, will challenge global public health and create new, untapped, market opportunities. ExoLytics aims to play a critical role in worldwide efforts to develop and commercialize alternatives to antibiotics.

Institute of Medical Sciences, Department of Microbiology, Banaras Hindu University, Varanasi, India

Phage dosage optimization, Customized Phage Therapy

institute-of-medical-sciences-department-of-microbiology-banaras-hindu-university-varanasi-india

Vésale Bioscience is a Belgian biotech, created in 2018 as a spin-out of Vésale Pharma.
We fight antibacterial multi-resistant infections (AMR) with our personalized phage therapy solutions:
1) We have developed a fast diagnostic tool Inteliphage®, an automated Phagogram®, which can be easily placed in hospital laboratories and that will recommend in a couple of hours (instead of days/weeks) the optimal phages association (2 or 3) from our phage library to fight the specific patient’s bacteria.
2) We will produce a library of phages in advance and speed deliver to hospitals the selected phages from the Phagogram® as API for tailored magistral preparations. This approach dramatically reduces the time-to-patient and increases the success rate of AMR treatments. This allows to treat acute and chronic infections at the hospital: already tested in more than 100 critically ill patients without major safety concerns. We expect to have our first sales in Europe in 2023.

PhagePro is a phage company that prioritizes global health. Our mission is to alleviate the burden of antibiotic resistance in vulnerable communities.

CreatiPhage is committed to developing innovative phage-based medicines and personalized therapies to address the global threat of antimicrobial resistance.

Laboratório de Microbiologia Aplicada

seoul-national-university-lab-kim,seoul-national-university-yang

In the Blower lab we work on phage-host interactions, researching a range of phage-resistance mechanisms such as abortive infection, restriction-modification, and BREX. We employ techniques that include genetics, microbiology, biochemistry and X-ray crystallography. Durham University is a Top 5 UK university, set in a UNESCO world heritage site in the North-East of England.

Phage isolation and genomic organization analysis

Sequencing, bioinformatics, access to datasets.
Access to clinical or environmental samples.
Phage lysin and Phage therapy

We carry out academic phage research.